- Home
- CDXS vs ARCT Comparison
CDXS vs ARCT Comparison
Compare CDXS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDXS | ARCT |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 217.7M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CDXS | ARCT |
|---|---|---|
| Price | $2.79 | $8.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | ★ 910.5K | 444.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.82 | 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $138,590,000.00 | $82,031,000.00 |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | $12.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $5.85 |
| 52 Week High | $3.87 | $24.14 |
Technical Indicators
Market Signals| Indicator | CDXS | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 54.65 |
| Support Level | $2.39 | $6.70 |
| Resistance Level | $2.87 | $9.14 |
| Average True Range (ATR) | 0.15 | 0.39 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 79.28 | 95.74 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.